Verve gets FDA green light to run base editing study in US
Bio Pharma Dive
OCTOBER 23, 2023
The trial, which is ongoing in the U.K. since late last year as the FDA sought more details on Verve’s in vivo treatment for heart disease. and New Zealand, has been on hold in the U.S.
Let's personalize your content